Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.61

+3.5%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mlkr who wrote (2928)	6/15/2010 10:46:20 AM
From: Jibacoa	Read Replies (2) of 3722

ATRC opened with a good UG after announcing yesterday AHs that it received FDA clearance for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion system. <g> The stock was up 37.66% and is still up 24.47% at present on volume >785Ks which is about 12x its ADV bigcharts.marketwatch.com The launch of the AtriClip system in the US is expected to start later this month. The AtriClip system provides a safe method to exclude the left atrial appendage. Stagnant blood within the trabeculations of the atrial apendage form clots that can then embolize to the brain or other important organs. The AtriClip is designed to be implanted from the outside of the heart and it eliminates blood flow between the left atrial appendage and the atria. It has been now cleared by the FDA for occlusion of the left atrial appendage, under direct visualization, in conjunction with other open-heart cardiac procedures. <g> The ACTAY is $7.64 The EL for the current Yr. is around $0.40 vs. $0.39 in 2009 It seems that with some good news the stock could get to test the resistance at the $10 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next